about
Non-Covalent Derivatives: Cocrystals and EutecticsPharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and DevelopmentSmall-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.New forms of old drugs: improving without changing.Application of UV Imaging in Formulation Development.Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs).Hydrogen bonding vs. halogen bonding: the solvent decides.Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour.In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.Drug-drug co-crystals.A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids.Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials.Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.Influences of Crystal Anisotropy in Pharmaceutical Process Development.Multicomponent solid forms of felodipine: preparation, characterisation, physicochemical and in-vivo studies.Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.Acidity and basicity interplay in amide and imide self-association.A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-CrystalsInvestigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystalMechanochemical synthesis and characterisation of cocrystals and metal organic compounds
P2860
Q26796674-5BE1D4DF-CBC8-470D-9244-C3DE563DE6F4Q28468556-E4C096FD-23C6-4628-989B-0016EB48CE16Q30375810-01561C68-BBD4-4DED-8E4E-FDD58FCC5642Q36442112-9C18D252-58EB-48F3-8DE4-14B8391483E1Q37155004-2F6843CC-13DC-4686-ADD1-E0A659898964Q38342804-132A56DF-1CCF-4263-8AAB-1910526F5DF4Q38808298-B9078CD5-6871-4D83-B549-FD07C503F211Q38865422-4B220BCB-8AEB-4C61-A96B-244BD7AD8D33Q38866596-1B558131-1A61-4216-8291-721FA676AFCDQ41853186-1F1B5FF8-6900-4AA4-8AC8-3FC18FFCB9A9Q41869235-82C7856A-06E4-49E9-BDF6-480E550CC4B6Q41888978-030E34FF-E173-46EE-A499-FE1B370A4670Q42658216-04FD6913-D677-4A58-80C1-065A0A762E14Q43004030-DD69496D-D801-4F47-8DA0-BDA951622116Q43776696-41073D4A-C4D1-4498-A844-0B99ED7003BBQ46465572-97F51D55-BD5D-4CB8-8E26-9B2D2C144BD9Q47294973-6ADA966B-5F68-414A-B5DE-588F11C9C7DEQ48314127-AF3CBBA5-DBF8-4A6B-943A-FE621C8F41E2Q48520512-B4EB6BA3-1E68-44B9-B1CA-EF2877167769Q51706707-03834B25-81AC-41C9-838C-2F810555BD75Q53430569-7C942AE8-2585-4848-A883-24F8D64173C7Q53540013-697B66F8-F90C-47EB-9B00-22D99F0AB56AQ53602825-DBDAA582-0392-4CBA-B883-15B7878DDF2FQ55344924-CFD1A326-A324-4EE7-801C-B66B2348BFCCQ57136283-68008F1B-DD0D-422E-9896-AD909C908179Q57162923-FAE7F386-52C0-4EAB-9957-0F655E5409A7Q57599110-9AF76626-BF61-4224-94FD-0745AD72AA34
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmaceutical cocrystals: an overview.
@en
Pharmaceutical cocrystals: an overview.
@nl
type
label
Pharmaceutical cocrystals: an overview.
@en
Pharmaceutical cocrystals: an overview.
@nl
prefLabel
Pharmaceutical cocrystals: an overview.
@en
Pharmaceutical cocrystals: an overview.
@nl
P2093
P1476
Pharmaceutical cocrystals: an overview.
@en
P2093
Angela Davies
Gary Trappitt
Mingzhong Li
Nazneen Malek
Walkiria Schlindwein
P356
10.1016/J.IJPHARM.2011.07.037
P407
P577
2011-08-02T00:00:00Z